Transcriptomic-based biomarker for detection of genotoxicants
Commonly used acronym: GENOMARK
Scope of the method
- Human health
- Basic Research
- In vitro - Ex vivo
- Human derived cells / tissues / organs
- gene expression biomarker
- MTT assay
- qPCR array
- human-derived metabolically competent cells
- in vitro toxicology
- hazard assessment
The GENOMARK tool in metabolically competent human HepaRG cells is based on the transcriptomic results obtained with 12 genotoxic (in vivo positive results) and 12 non-genotoxic (in vivo negative results) reference compounds. Genotoxic compounds were selected to cover different mechanisms of action including bulky adduct formation, DNA alkylation, cross-linking, radical generation causing DNA strand breaks, inhibition of tubulin polymerization and base analogues. The GENOMARK biomarker includes 84 genes (+ 5 housekeeping genes) of which the expression can be assessed in an easy-to-handle qPCR array. Briefly, after cultivation for 7 days, cells are exposed for 72 hours to the test compound at the IC10 concentration as determined by an MTT test (cytotoxicity formazan-forming test). Next, RNA is isolated and transcribed to cDNA which is applied on the qPCR pre-spotted plate to investigate the expression of the 84 genes included in the GENOMARK tool. Gene expression results are analyzed in R (software environment for statistical computing and graphics). All experiments are performed in triplicate with different batches of HepaRGTM cells to ensure reproducibility.
- - Standard equipment for working with cell cultures;
- - Vacuum system;
- - Water bath;
- - Nanodrop spectrophotometer;
- - Centrifuge;
- - Vortex mixer;
- - Shaker for microtiter plate;
- - Bio-rad CFX qPCR instrument;
- - PCR cycler;
- - R software;
- - GraphPad software;
- - Cold rack (-20°C);
- - Automatic cell counter or microscope with cell count chamber.
- Internally validated
- Published in peer reviewed journal
Pros, cons & Future potential
- - Selected genes represent different pathways involved in the DNA damage response;
- - All pro-genotoxins included as reference or test compound were correctly classified.
- - No standalone test, but an important part of an integrated testing strategy;
- - Further validation needed;
- - Only one dose is tested, problems with unstable compounds that might result in an unreliable IC10 value (introducing an IC10 control in the main test).
- - Faster procedure to determine IC10 concentration;
- - Higher throughput methodology to investigate gene expression.
References, associated documents and other information
A novel genotoxin-specific qPCR array based on the metabolically competent human HepaRG™ cell line as a rapid and reliable tool for improved in vitro hazard assessment. Gamze Ates, Birgit Mertens, Anja Heymans, Luc Verschaeve, Dimiter Milushev, Philippe Vanparys, Nancy H. C. Roosens, Sigrid C. J. De Keersmaecker, Vera Rogiers, Tatyana Y. Doktorova.
Short presentation GENOMARK at the EUROTOX congress
Contact personAnouck Thienpont
Chemical and physical health risks
Risk and Health Impact Assessment
Vrije Universiteit Brussel (VUB)
Pharmaceutical and Pharmacological Sciences
In Vitro Toxicology and Dermato-Cosmetology